Company Quick10K Filing
UQM Technologies
10-Q 2019-03-31 Filed 2019-05-14
10-K 2018-12-31 Filed 2019-03-27
10-Q 2018-09-30 Filed 2018-10-31
10-Q 2018-06-30 Filed 2018-08-01
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-20
10-Q 2017-09-30 Filed 2017-11-02
10-Q 2017-06-30 Filed 2017-08-07
10-Q 2017-03-31 Filed 2017-05-11
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-04
10-K 2016-03-31 Filed 2016-06-07
10-Q 2015-12-31 Filed 2016-02-04
10-Q 2015-09-30 Filed 2015-11-10
10-Q 2015-06-30 Filed 2015-07-30
10-K 2015-03-31 Filed 2015-05-28
10-Q 2014-12-31 Filed 2015-02-05
10-Q 2014-09-30 Filed 2014-11-05
10-Q 2014-06-30 Filed 2014-07-31
10-K 2014-03-31 Filed 2014-05-30
10-Q 2013-12-31 Filed 2014-01-30
10-Q 2013-09-30 Filed 2013-11-05
10-Q 2013-06-30 Filed 2013-08-01
10-K 2013-03-31 Filed 2013-05-23
10-Q 2012-12-31 Filed 2013-01-31
10-Q 2012-09-30 Filed 2012-10-25
10-Q 2012-06-30 Filed 2012-07-31
10-K 2012-03-31 Filed 2012-05-24
10-Q 2011-12-31 Filed 2012-01-31
10-Q 2011-09-30 Filed 2011-10-27
10-Q 2011-06-30 Filed 2011-08-01
10-K 2011-03-31 Filed 2011-06-02
10-Q 2010-12-31 Filed 2011-02-01
10-Q 2010-09-30 Filed 2010-10-28
10-Q 2010-06-30 Filed 2010-07-29
10-K 2010-03-31 Filed 2010-05-24
10-Q 2009-12-31 Filed 2010-02-02
8-K 2019-07-31
8-K 2019-07-25
8-K 2019-05-14
8-K 2019-04-23
8-K 2019-04-16
8-K 2019-03-27
8-K 2019-01-21
8-K 2018-10-31
8-K 2018-10-17
8-K 2018-08-01
8-K 2018-05-10
8-K 2018-05-09
8-K 2018-03-20
8-K 2018-03-05
8-K 2017-07-12

UQM Technologies Financials

UQM Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash10,93212,11011,54511,6388,7496,7805,9054,5285,3355,0716,26410,2479,4598,0477,2176,5865,6274,0188,6897,0305,4983,8621,0882,6608,5786,8095,9103,0092,8462,2153,133
Accounts Receivable2,9682,6343,9534,9295,5974,7581,4302,2122,7263,0836839608901,0158965224156796634816794844777926348241,3471,1971,2871,6811,541
Inventory3,0004,2577,99210,56412,21813,42811,41010,99810,75910,52810,25510,0549,9409,7509,6529,3549,3759,0109,0022,2719,0539,1502,0992,3572,6892,3412,8813,9104,5754,7844,816
PP&E13,16113,40113,67514,03614,20314,24814,30013,97114,10814,24814,40813,90613,92813,95314,00913,23713,28413,29213,29413,28913,30513,30713,26312,50312,51212,54912,58112,74012,82612,89213,132
Assets39,66438,85539,72239,65638,69636,97330,10628,60927,97527,78626,41229,83528,66126,85025,47824,80222,78120,79125,21223,35121,82819,94110,43311,86617,15415,13415,36113,44314,18914,01414,974
Accounts Payable8091,1521,9042,3571,4531,5498516178957055523863633511693994975953953658197828329521,3899491,1381,7432,6452,9962,679
Long-Term Debt5913,1653,1653,1653,1654,6654,665
Liabilities2,4002,6304,2255,4085,5195,7833,2083,8443,9603,8902,3802,0602,0032,1251,9712,4732,5152,6762,5671,6392,0082,2902,9735,6716,2375,3637,4317,6659,39710,00010,813
Stockholders' Equity37,26436,22535,49734,24833,17731,18926,89724,76524,01523,89624,03227,77526,65824,72623,50722,32920,26618,11522,64521,71219,82017,6517,4606,19510,9179,7717,9305,7784,7924,0144,161
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Revenue1,3152,3342,7193,7752,3961,1961,9281,6581,9492,0622,0401,0151,0201,1178361,0447411,7351,3271,5041,4351,0211,0151,7892,7532,2221,6122,7024,3855,4763,684
Cost of Revenue1,1996659091,1131,4064,175
Gross Profit4603501353918161,301
R&D41626132723415591446184133409141,088912775684719882633555403451679827397502
SG&A1,1902,0991,1501,2411,8233,1461,4341,2921,2441,6151,2201,0641,1291,7721,1341,3041,2451,8551,0731,2331,6851,7381,3031,4711,9831,6101,5202,3191,8402,692
Tax
Net Income-1,044-1,586-846-1,452-1,287-2,564-4,555-2,282-9163,226-66-1,379-1,310-1,991-1,371-1,316-2,224-2,409-1,374-931-1,954-2,368-1,606-586-543-1,281-1,933-2,470-1,142-959-2,551
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash Operating-2,478-2,429-3,679-2,827-3,176-1,726-1,104-1,254-541-2381,357-1,200-886-1,121-765-931-1,499-1,154-1,522-1,628-997-1,516-585-1,772-871-2,719-61-1,385
Cash Investing-2,4903,6193,1142,882272-219185-1241,344-43-19424171-118-65-49-18-23-20-11-16-291,378-54-46-197-108-255
Cash Financing22-1103816-24430418294,94327-172022-915,8479323,1165,12458181572,558